State of Alaska Department of Revenue’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.49M | Sell |
40,107
-14,749
| -27% | -$891K | 0.03% | 439 |
|
|
2026
Q1 | $2.21M | Sell |
54,856
-1,456
| -3% | -$54.4K | 0.02% | 663 |
|
|
2025
Q4 | $1.96M | Buy |
56,312
+9,147
| +19% | +$718K | 0.02% | 714 |
|
|
2025
Q3 | $3.92M | Sell |
47,165
-9,050
| -16% | -$655K | 0.04% | 424 |
|
|
2025
Q2 | $4.13M | Buy |
56,215
+4,546
| +9% | +$330K | 0.04% | 404 |
|
|
2025
Q1 | $5.9M | Sell |
51,669
-1,327
| -3% | -$80.8K | 0.07% | 269 |
|
|
2024
Q4 | $2.67M | Sell |
52,996
-49
| -0.1% | -$2.57K | 0.03% | 546 |
|
|
2024
Q3 | $2.45M | Sell |
53,045
-746
| -1% | -$26.5K | 0.03% | 644 |
|
|
2024
Q2 | $1.75M | Sell |
53,791
-1,469
| -3% | -$40.2K | 0.02% | 727 |
|
|
2024
Q1 | $1.39M | Sell |
55,260
-257
| -0.5% | -$6.07K | 0.02% | 860 |
|
|
2023
Q4 | $1.8M | Sell |
55,517
-669
| -1% | -$18.4K | 0.02% | 732 |
|
|
2023
Q3 | $1.53M | Sell |
56,186
-3,298
| -6% | -$95.5K | 0.02% | 745 |
|
|
2023
Q2 | $1.32M | Sell |
59,484
-6,124
| -9% | -$141K | 0.02% | 831 |
|
|
2023
Q1 | $1.42M | Sell |
65,608
-1,006
| -2% | -$22.1K | 0.02% | 809 |
|
|
2022
Q4 | $1.35M | Buy |
66,614
+619
| +0.9% | +$15.5K | 0.02% | 809 |
|
|
2022
Q3 | $1.69M | Sell |
65,995
-6,289
| -9% | -$168K | 0.02% | 684 |
|
|
2022
Q2 | $1.72M | Buy |
72,284
+5,775
| +9% | +$126K | 0.02% | 713 |
|
|
2022
Q1 | $1.5M | Sell |
66,509
-690
| -1% | -$14.7K | 0.02% | 775 |
|
|
2021
Q4 | $1.33M | Sell |
67,199
-8,910
| -12% | -$181K | 0.01% | 918 |
|
|
2021
Q3 | $1.5M | Buy |
76,109
+3,468
| +5% | +$72.6K | 0.02% | 856 |
|
|
2021
Q2 | $1.6M | Buy |
72,641
+1,170
| +2% | +$26K | 0.02% | 827 |
|
|
2021
Q1 | $1.7M | Sell |
71,471
-9,910
| -12% | -$265K | 0.02% | 748 |
|
|
2020
Q4 | $2.13M | Sell |
81,381
-15,925
| -16% | -$336K | 0.02% | 586 |
|
|
2020
Q3 | $1.69M | Buy |
97,306
+10
| +0% | +$159 | 0.02% | 631 |
|
|
2020
Q2 | $1.64M | Buy |
97,296
+6,090
| +7% | +$85.6K | 0.02% | 650 |
|
|
2020
Q1 | $1.08M | Buy |
91,206
+13,540
| +17% | +$168K | 0.02% | 727 |
|
|
2019
Q4 | $939K | Sell |
77,666
-938
| -1% | -$13.1K | 0.01% | 945 |
|
|
2019
Q3 | $1.11M | Buy |
78,604
+43,024
| +121% | +$529K | 0.02% | 804 |
|
|
2019
Q2 | $396K | Buy |
35,580
+393
| +1% | +$4.38K | 0.01% | 1185 |
|
|
2019
Q1 | $413K | Buy |
35,187
+50
| +0.1% | +$621 | 0.01% | 1157 |
|
|
2018
Q4 | $469K | Buy |
35,137
+943
| +3% | +$12.5K | 0.01% | 999 |
|
|
2018
Q3 | $479K | Buy |
34,194
+2,924
| +9% | +$40.9K | 0.01% | 1132 |
|
|
2018
Q2 | $491K | Buy |
31,270
+510
| +2% | +$8.87K | 0.01% | 1079 |
|
|
2018
Q1 | $506K | Buy |
30,760
+13,020
| +73% | +$241K | 0.01% | 947 |
|
|
2017
Q4 | $320K | Buy |
+17,740
| New | +$321K | 0.01% | 1010 |
|
Other funds holding CORT
PA
EA
State of Alaska Department of Revenue's CORT Position: Q2 2026 in Review
State of Alaska Department of Revenue reduced its Corcept Therapeutics (CORT) stake by 27% in Q2 2026, selling an estimated $891K and leaving 40,107 shares worth $3.49M. The position accounts for 0.03% of the portfolio, ranked #439.
State of Alaska Department of Revenue first reported a position in CORT in Q4 2017 and has held it in 35 quarters since. The position peaked at $5.9M in Q1 2025. 273 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- State of Alaska Department of Revenue held 40,107 shares of Corcept Therapeutics worth $3.49M as of Q2 2026.
- State of Alaska Department of Revenue sold 14,749 Corcept Therapeutics shares in Q2 2026, an estimated $891K.
- Corcept Therapeutics made up 0.03% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #439 holding.
- State of Alaska Department of Revenue first reported a position in Corcept Therapeutics in Q4 2017 and has held it in 35 quarters since.
- State of Alaska Department of Revenue's Corcept Therapeutics position peaked at $5.9M in Q1 2025.
- 273 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.